US Fertility

Oova Inc. is a New York-based company that specializes in personalized fertility diagnostics. Founded in 2017 and spun out from Mount Sinai Hospital, Oova develops a fertility test kit that utilizes a paper-based strip to measure key hormones present in women’s urine. This innovative device allows users to monitor their fertility profile over time through daily urine samples, leveraging patent-pending biochemistry and artificial intelligence. By accurately tracking hormone levels, Oova aids women in cycle management, assesses menstrual health post-pregnancy, and identifies reproductive health issues such as polycystic ovary syndrome (PCOS). The system is designed for convenience, enabling women to achieve their conception goals without significantly disrupting their daily routines, while providing valuable insights to both patients and healthcare providers through real-time testing and wellness guidance via a mobile application.

Ovation Fertility is a network of reproductive medicine facilities that specializes in providing advanced in vitro fertilization (IVF) services. The company focuses on delivering high-quality patient care through innovative techniques and leading-edge treatments. Its team consists of renowned physicians who have a proven track record in the field of reproductive medicine. Ovation Fertility offers a comprehensive range of services, including IVF laboratory services, genetic testing, donor egg programs, surrogacy, and fertility preservation. By integrating these services, Ovation Fertility aims to enhance the efficiency and effectiveness of fertility care, ultimately reducing the financial burden on patients seeking to achieve successful pregnancies.